First investigational medicine to show positive study results in both primary progressive and relapsing MS

First investigational medicine to show positive study results in both primary progressive and relapsing MS Ocrelizumab, first and only treatment to show positive results in primary progressive MS Phase III clinical study, where all previous Phase III studies with MS medications have been negative
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics Neurology Patient care ECTRIMS Latest News neurodegenerative disorder Ocrelizumab OPERA I OPERA II ORATORIO ppms rms Source Type: news